EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"Burk, Robin"
Narrow search

Narrow search

Year of publication
Subject
All
COVID-19 2 Cost 2 Cost-effectiveness 2 Germany 2 Surveillance 2 Coronavirus 1 Cost-benefit analysis 1 Cost-effectiveness analysis 1 Costs 1 Deutschland 1 Impact assessment 1 Infectious disease 1 Infektionskrankheit 1 Kosten 1 Kosten-Nutzen-Analyse 1 Kosten-Wirksamkeits-Analyse 1 Wirkungsanalyse 1
more ... less ...
Online availability
All
Free 2
Type of publication
All
Article 2
Type of publication (narrower categories)
All
Article 1 Article in journal 1 Aufsatz in Zeitschrift 1
Language
All
English 2
Author
All
Brenner, Stephan 2 Brugnara, Lucia 2 Burk, Robin 2 Bärnighausen, Till 2 De Allegri, Manuela 2 Deckert, Andreas 2 Denkinger, Claudia M. 2 Knop, Michael 2 Nguyen, Hoa Thi 2 Koeppel, Lisa 1 Köppel, Lisa 1
more ... less ...
Published in...
All
The European Journal of Health Economics 1 The European journal of health economics 1
Source
All
ECONIS (ZBW) 1 EconStor 1
Showing 1 - 2 of 2
Cover Image
Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies : evidence from a randomised control trial in Germany
Nguyen, Hoa Thi; Denkinger, Claudia M.; Brenner, Stephan; … - In: The European journal of health economics 24 (2023) 9, pp. 1545-1559
Persistent link: https://www.econbiz.de/10014427374
Saved in:
Cover Image
Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany
Nguyen, Hoa Thi; Denkinger, Claudia M.; Brenner, Stephan; … - In: The European Journal of Health Economics 24 (2023) 9, pp. 1545-1559
Introduction: The COVID-19 pandemic has entered its third year and continues to affect most countries worldwide. Active surveillance, i.e. testing individuals irrespective of symptoms, presents a promising strategy to accurately measure the prevalence of SARS-CoV-2. We aimed to identify the most...
Persistent link: https://www.econbiz.de/10015328816
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...